143 related articles for article (PubMed ID: 38180895)
1.
Zhang SL; Yu HJ; Lian ZQ; Wan J; Xie SM; Lei W; Chen QP; Zhang L; Wang Q
J Int Med Res; 2024 Jan; 52(1):3000605231220827. PubMed ID: 38180895
[TBL] [Abstract][Full Text] [Related]
2. Septin9 DNA methylation as a promising biomarker for cervical cancer.
Bu Q; Luo X; He L; Ma J; He S; Lei W; Zhou W; Deng H; Lin Y; Zhang L; Hong X
J Obstet Gynaecol; 2023 Dec; 43(1):2151356. PubMed ID: 36476308
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer.
Roperch JP; Grandchamp B; Desgrandchamps F; Mongiat-Artus P; Ravery V; Ouzaid I; Roupret M; Phe V; Ciofu C; Tubach F; Cussenot O; Incitti R
BMC Cancer; 2016 Sep; 16(1):704. PubMed ID: 27586786
[TBL] [Abstract][Full Text] [Related]
4. CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patients.
Dietrich D; Krispin M; Dietrich J; Fassbender A; Lewin J; Harbeck N; Schmitt M; Eppenberger-Castori S; Vuaroqueaux V; Spyratos F; Foekens JA; Lesche R; Martens JW
BMC Cancer; 2010 Jun; 10():247. PubMed ID: 20515469
[TBL] [Abstract][Full Text] [Related]
5. Analyzing the Role of Septin9 Gene Methylation in the Diagnosis and Treatment of Primary Liver Cancer in the Elderly.
Liu H; Wei D; Yan Z; Cui B; Song Y; Yin H
Altern Ther Health Med; 2023 May; 29(4):194-199. PubMed ID: 36947654
[TBL] [Abstract][Full Text] [Related]
6. [Significance of Septin9 gene methylation detection of plasma circulation DNA in colorectal cancer screening].
Kang Q; Jin P; Yang L; Wang X; An H; Liu L; Li N; Sheng J
Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(48):3839-41. PubMed ID: 25623318
[TBL] [Abstract][Full Text] [Related]
7. [Promoter methylation of ID4. A marker for recurrence-free survival in human breast cancer].
Noetzel E; Veeck J; Horn F; Hartmann A; Knüchel R; Dahl E
Pathologe; 2008 Nov; 29 Suppl 2():319-27. PubMed ID: 18807039
[TBL] [Abstract][Full Text] [Related]
8. Dual-modality loop-mediated isothermal amplification for pretreatment-free detection of Septin9 methylated DNA in colorectal cancer.
Lin Q; Fang X; Chen H; Weng W; Liu B; Kong J
Mikrochim Acta; 2021 Aug; 188(9):307. PubMed ID: 34453211
[TBL] [Abstract][Full Text] [Related]
9. Detection of Circulating Tumor DNA Methylation in Diagnosis of Colorectal Cancer.
Xu F; Yu S; Han J; Zong M; Tan Q; Zeng X; Fan L
Clin Transl Gastroenterol; 2021 Aug; 12(8):e00386. PubMed ID: 34382948
[TBL] [Abstract][Full Text] [Related]
10. Sox17 promoter methylation in plasma DNA is associated with poor survival and can be used as a prognostic factor in breast cancer.
Fu D; Ren C; Tan H; Wei J; Zhu Y; He C; Shao W; Zhang J
Medicine (Baltimore); 2015 Mar; 94(11):e637. PubMed ID: 25789956
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation in sentinel lymph nodes as a marker for breast cancer recurrence.
Carraway HE; Wang S; Blackford A; Guo M; Powers P; Jeter S; Davidson NE; Argani P; Terrell K; Herman JG; Lange JR
Breast Cancer Res Treat; 2009 Mar; 114(2):315-25. PubMed ID: 18404369
[TBL] [Abstract][Full Text] [Related]
12. External quality assessment for detection of colorectal cancer by Septin9 DNA methylation in clinical laboratories.
Chang L; Wang D; Han Y; Diao Z; Chen Y; Li J; Zhang R
Clin Chim Acta; 2024 Jan; 552():117663. PubMed ID: 38008152
[TBL] [Abstract][Full Text] [Related]
13. High RASSF1A promoter methylation levels are predictive of poor prognosis in fine-needle aspirate washings of breast cancer lesions.
Martins AT; Monteiro P; Ramalho-Carvalho J; Costa VL; Dinis-Ribeiro M; Leal C; Henrique R; Jerónimo C
Breast Cancer Res Treat; 2011 Aug; 129(1):1-9. PubMed ID: 20842524
[TBL] [Abstract][Full Text] [Related]
14. Methylation of ASC/TMS1 promoter is associated with poor prognosis of patients with gastric cancer.
Wu L; Zhang C; Wang X; Ding X; Deng J; Liang H
Clin Transl Oncol; 2016 Mar; 18(3):296-303. PubMed ID: 26260914
[TBL] [Abstract][Full Text] [Related]
15. Postoperative serum methylation levels of TAC1 and SEPT9 are independent predictors of recurrence and survival of patients with colorectal cancer.
Tham C; Chew M; Soong R; Lim J; Ang M; Tang C; Zhao Y; Ong SY; Liu Y
Cancer; 2014 Oct; 120(20):3131-41. PubMed ID: 24925595
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation of protocadherin8 is an independent prognostic factor for biochemical recurrence of early-stage prostate cancer.
Niu WB; Gui SL; Lin YL; Fu XL; Ma JG; Li WP
Med Sci Monit; 2014 Dec; 20():2584-9. PubMed ID: 25486497
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer.
Noetzel E; Veeck J; Niederacher D; Galm O; Horn F; Hartmann A; Knüchel R; Dahl E
BMC Cancer; 2008 May; 8():154. PubMed ID: 18513385
[TBL] [Abstract][Full Text] [Related]
18. Quantitative DNA methylation and recurrence of breast cancer: a study of 30 candidate genes.
Cheol Kim D; Thorat MA; Lee MR; Cho SH; Vasiljević N; Scibior-Bentkowska D; Wu K; Ahmad AS; Duffy S; Cuzick JM; Lorincz AT
Cancer Biomark; 2012; 11(2-3):75-88. PubMed ID: 23011154
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic changes of CXCR4 and its ligand CXCL12 as prognostic factors for sporadic breast cancer.
Ramos EA; Grochoski M; Braun-Prado K; Seniski GG; Cavalli IJ; Ribeiro EM; Camargo AA; Costa FF; Klassen G
PLoS One; 2011; 6(12):e29461. PubMed ID: 22220212
[TBL] [Abstract][Full Text] [Related]
20. [The effect of axillary lymph node status on the prognosis of patients with local-regional recurrence after breast-conserving surgery].
Zhang Z; Zhang W; Li ZJ; Wang XM; Cao XC; Xiao CH
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):347-351. PubMed ID: 29860761
[No Abstract] [Full Text] [Related]
[Next] [New Search]
